Triomics - About the company
Triomics is a series B company based in San Francisco (United States), founded in 2020 by Hrituraj Singh and Sarim Khan. It operates as a Provider of clinical research and clinical trial tracking software. Triomics has raised $50.9M in funding from Y Combinator and Battery Ventures. The company has 303 active competitors, including 54 funded and 42 that have exited. Its top competitors include companies like Medidata, Verily and IQVIA.
Company Details
Provider of clinical research and clinical trial tracking software. The features of the software include an end-to-end platform for running clinical trials, unifying the workflows of clinical care and clinical research, and eliminating the operational inefficiencies in data collection, patient recruitment, and other laborious tasks involved in clinical research.
- Website
- www.triomics.com/
- Email ID
- *****@triomics.com
- Phone Number
- +1 **********
- Registered Address
- VILLA NO. D-103, PLOT NO. BGH-A, UPSIDC HOUSING SECTOR, Gautam Buddha Nagar, SURAJPUR, Uttar Pradesh, India, 201310
Key Metrics
Founded Year
2020
Location
San Francisco, United States
Stage
Series B
Total Funding
$50.9M in 4 rounds
Latest Funding Round
Investors
Ranked
25th among 303 active competitors
Employee Count
1 as on May 31, 2026
Legal entities associated with Triomics
Triomics is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
TRIOMICS HEALTHCARE PRIVATE LIMITED CIN: U85300UP2020PTC136648 , India, Active | Oct 20, 2020 | 0 - ₹10 Cr (As on Mar 31, 2025) | 36 (As on May 01, 2026) | |
Triomics, Inc CIN: 861771548 , United States, Active | - | 10 (As on Dec 31, 2024) | - |
Sign up to download Triomics' company profile
Triomics's funding and investors
Triomics has raised a total funding of $50.9M over 4 rounds. Its first funding round was on 2021. Its latest funding round was a Series B round on May 28, 2026 for $*****. 4 investors participated in its latest round. Triomics has 6 institutional investors.
Here is the list of recent funding rounds of Triomics:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 28, 2026 | 9621991 | Series B | 6053197 | 3362809 | 9148238 | 5843973 |
May 09, 2024 | 7872663 | Series A | 5468923 | 7164410 | 1618971 | |
Dec 12, 2022 | 2293318 | Series A | 3781890 | 8448362 | 4154631 | 2186605 |
View details of Triomics's funding rounds and investors
Triomics' founders and board of directors
Founder? Claim ProfileHere are the details of Triomics' key team members:
- Hrituraj Singh: Co-Founder & CTO of Triomics. Contact Info: 1 email address
- Sarim Khan: Co-Founder & CEO of Triomics. Contact Info: 1 email address
View details of Triomics's Founder profiles and Board Members
Triomics' employee count trend
Triomics has 1 employees as of May 26. Here is Triomics's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Triomics's Competitors and alternates
Top competitors of Triomics include Medidata, Verily and IQVIA. Here is the list of Top 10 competitors of Triomics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Medidata 1999, New York City (United States), Acquired | AI-based clinical trial management software for researchers | $41.5M | 86/100 | |
2nd | Verily 2015, Dallas (United States), Series D | A data platform and technology company purpose-built to power AI-enabled precision health | $2.8B | 82/100 | |
3rd | IQVIA 1982, Durham (United States), Public | Provider of clinical research and commercialization solutions for healthcare | $1.74M | 80/100 | |
4th | Tempus 2015, Chicago (United States), Public | Developer of genomic testing and artificial intelligence tools for medicine | $1.05B | 78/100 | |
5th | Signant Health 2000, Plymouth Meeting (United States), Acquired | Provider of a software solution for clinical trial management | $3.4M | 72/100 | |
6th | Science 37 2014, Los Angeles (United States), Acquired | Provider of a suite solution for clinical trials for researchers | $106M | 70/100 | |
7th | Viz.ai 2016, San Francisco (United States), Series D | Developer of an AI-powered platform for care coordination and disease detection | $252M | 69/100 | |
8th | Massive Bio 2014, New York City (United States), Series B | Provider of AI-based clinical trial management tool | $15.6M | 67/100 | |
9th | TriNetX 2013, Cambridge (United States), Acquired | Provider of clinical trial management software for researchers and professionals | $102M | 66/100 | |
10th | BrightInsight 2017, San Jose (United States), Series C | Provider of digital health solutions for clinical trials | $179M | 64/100 | |
25th | Triomics 2020, San Francisco (United States), Series B | Provider of clinical research and clinical trial tracking software | $50.9M | 56/100 |
Looking for more details on Triomics's competitors? Click here to see the top ones
Triomics's Investments and acquisitions
Triomics has made no investments or acquisitions yet.
Reports related to Triomics
Here is the latest report on Triomics's geography:
News related to Triomics
Media has covered Triomics for a total of 6 events in the last 1 year, 1 of them has been about company updates and 1 about partnerships.
•
Beacon has raised $225 Million in new Series C fundingintelligence360•Jun 17, 2026•Beacon, General Catalyst, HarbourVest Partners, Lightspeed and 14 others
•
Triomics Secures $22 Million in Series B Funding for AI Cancer PlatformStartup Log•May 28, 2026•Triomics, Battery Ventures, Lightspeed, Y Combinator
•
Triomics nabs $22M to bring oncology-specific AI to cancer centersTechCrunch+•May 27, 2026•Battery Ventures, Triomics
•
•
Triomics: Oncology Workflow Automation Company Raises $15 MillionPulse 2.0•May 21, 2024•Triomics, Lightspeed, Nexus Venture Partners, General Catalyst and 1 other
•
US-based Triomics snaps $15M to automate oncology workflows with Generative AITech Funding News•May 09, 2024•Triomics, Y Combinator, Lightspeed Venture Partners, General Catalyst and 2 others
•
Are you a Founder ?
FAQs about Triomics
Explore our recently published companies
- ReFrame Engage - United States based, 2020 founded, Unfunded company
- Web Instant Messenger - Bolzano based, 2016 founded, Unfunded company
- Carekro - 2018 founded, Unfunded company
- Dnyhospitality - Unfunded company
- Doral SEO - Doral based, 2026 founded, Unfunded company
- EMJ - Italy based, 2026 founded, Unfunded company
